Real-world comparison of efficacy and safety of XEN45 implant with phacoemulsification versus iStent inject® W with phacoemulsification
Both procedures achieved similar surgical success rates, with comparable reductions in IOP and the number of antiglaucoma medications. After one year, a modest IOP reduction of 10.83% was observed in the iStent group and 13.65% in the Xen group. However, the iStent inject® W demonstrated a better intraoperative and postoperative safety profile.
Authors
- Juan J. Pérez-Santonja (ORCID: https://orcid.org/0000-0003-1892-2372)
- Angi Lizbeth Mendoza-Moreira (ORCID: https://orcid.org/0000-0001-8643-7593)
- María Teresa Marcos-Parra
- E. España-Vera
- Shiza Bari
- J Ezbakhe
- M C Calatayud-Hernández
Institutions
- Johannes Gutenberg University Mainz (DE)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
Publication Details
- Journal
- Journal Français d Ophtalmologie
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1016/j.jfo.2025.104469
- Citations
- 1
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.71